BioSpace News Archive

GlobeStar Therapeutics Corporation and Advanced Innovative Partners announced that they have entered into a memorandum of understanding collaboration agreement to design and implement clinical trials for Project Amethyst™, a compound intended to treat neurodegeneration from Multiple Sclerosis.

Coeptis Therapeutics Holdings, Inc. announced the pricing of an underwritten offering for gross proceeds of approximately $3.5 million to a single healthcare focused investor prior to deducting underwriting discounts and commissions and offering expenses.

Stealth BioTherapeutics Inc. provided key takeaways from a presentation by Reenie McCarthy, the Company’s Chief Executive Officer, at the World Orphan Drug Congress USA, held May 23-25 in Washington, D.C.

Toronto, Ontario--(Newsfile Corp. - June 14, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the “Company” or “Telo”) announces that it has closed its previously announced non-brokered private placement (“Offering”) of units (the “Units”).

Toronto, Ontario--(Newsfile Corp. - June 13, 2023) - Neural Therapeutics Inc. (the “Company” or “Neural”) an ethnobotanical drug-discovery and development company announces it is undertaking a rights offering to raise gross proceeds of up to $1,184,080 (the “Rights Offering”) and a non-brokered private placement of up to $900,000 (“Concurrent Private Placement”).

A devastated mother from Vermont has revealed how a common cough led to her baby being diagnosed with a rare, incurable and deadly disease.

ERYTECH Pharma, announced that the Lyon Commercial Court has rejected Akkadian’s request to postpone the vote on the merger with Pherecydes Pharma.

Tobra Medical, a specialty medical device company focused on micro surgery, announced the product launch of Tobra FeatherFlow.

Avid Bioservices, Inc. announced that it will report financial results for the quarter and fiscal year ended April 30, 2023 on June 21, 2023, after market close and will host a webcast at 1:30 PM Pacific Time.

Biora Therapeutics, Inc. announced the closing of its previously announced registered direct offering of an aggregate of 1,509,434 shares of the Company’s common stock at an offering price of $5.30 per share of common stock and concurrent private placement of warrants to purchase up to 3,018,868 shares of common stock.